Optimized Therapy in Severe Traumatic Brain Injured Patients
Status:
Completed
Trial end date:
2011-02-01
Target enrollment:
Participant gender:
Summary
Severe traumatic brain injury is associated with life-threatening and incapacitating
secondary injury.
Contemporary therapeutic interventions are aimed at preventing and treating secondary damage.
In this context, improved cerebral metabolism is an important target in modern neurointensive
care.
The main hypothesis is that continuous intravenous infusion of glutamyl-alanyl dipeptide
restores disturbed brain metabolism following severe traumatic brain injury.
Phase:
Phase 4
Details
Lead Sponsor:
University of Zurich
Collaborators:
Fresenius Kabi Swiss National Science Foundation University Hospital, Zürich